DCGI to take a final call on granting market approval to Covishield, Covaxin
The Subject Expert Committee on Wednesday had recommended an upgrade the status of Covishield and Covaxin from restricted use in emergencies to grant of new drug permission with conditions in the adult population. The Drugs Controller General of India (DCGI) will take a final decision on granting market approval to two Covid-19 vaccines in the … Read more